Phenominer Database Results (124 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Record ID Study ID
SD-Fhem1+/+ mean corpuscular hemoglobin concentration control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount male 0 days 3 3367.0 g/dl 3.46 6.0 automated blood analysis 0.0 0 104881 2989
SD-Fhem1+/+ blood monocyte count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. monocyte quantity male 0 days 3 4.6 % 0.06 0.1 automated blood analysis 0.0 0 104889 2989
SD-Fhem1+/+ platelet-large cell ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait female 0 days 3 14.8 % 0.87 1.5 automated blood analysis 0.0 0 104922 2989
SD-Fhem1+/+ blood alanine aminotransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood alanine transaminase amount male 0 days 3 47.3 U/l 1.79 3.1 automated blood analysis 0.0 0 104925 2989
SD-Fhem1+/- blood alanine aminotransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood alanine transaminase amount female 0 days 3 35.8 U/l 6.64 11.5 automated blood analysis 0.0 0 104928 2989
SD-Fhem1+/- blood gamma-glutamyltransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood gamma-glutamyltransferase amount female 0 days 3 1.8 U/l 0.29 0.5 automated blood analysis 0.0 0 104936 2989
SD-Fhem1+/+ plasma direct bilirubin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood bilirubin amount male 0 days 3 0.2 umol/l 0.06 0.1 automated blood analysis 0.0 0 104945 2989
SD-Fhem1+/+ hematocrit control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte quantity female 0 days 3 39.9 % 1.91 3.3 automated blood analysis 0.0 0 104858 2989
SD-Fhem1+/+ platelet count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet quantity male 0 days 3 1106.3 x 1000 cells/ul 86.83 150.4 automated blood analysis 0.0 0 104861 2989
SD-Fhem1+/- platelet count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet quantity male 0 days 3 1004.0 x 1000 cells/ul 80.6 139.6 automated blood analysis 0.0 0 104863 2989
SD-Fhem1+/+ mean platelet volume control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait female 0 days 3 8.5 fl 0.12 0.2 automated blood analysis 0.0 0 104866 2989
SD-Fhem1+/- mean corpuscular volume control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait female 0 days 3 51.4 fl 0.64 1.1 automated blood analysis 0.0 0 104876 2989
SD-Fhem1+/- blood eosinophil count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. eosinophil quantity female 0 days 3 0.03 x 1000 cells/ul 0.0 0.0 automated blood analysis 0.0 0 104908 2989
SD-Fhem1+/- blood glucose level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood glucose amount female 0 days 3 108.0 mg/dl 12.47 21.6 automated blood analysis 0.0 0 104968 2989
SD-Fhem1+/- white blood cell count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. leukocyte quantity female 0 days 3 3.0 x 1000 cells/ul 0.23 0.4 automated blood cell counting method 0.0 0 104836 2989
SD-Fhem1+/+ blood protein measurement control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood total protein amount male 0 days 3 644.0 g/dl 9.24 16.0 automated blood analysis 0.0 0 104953 2989
SD-Fhem1+/- blood protein measurement control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood total protein amount female 0 days 3 677.0 g/dl 16.74 29.0 automated blood analysis 0.0 0 104956 2989
SD-Fhem1+/+ platelet count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet quantity female 0 days 3 1152.3 x 1000 cells/ul 118.82 205.8 automated blood analysis 0.0 0 104862 2989
SD-Fhem1+/+ mean platelet volume control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait male 0 days 3 8.7 fl 0.17 0.3 automated blood analysis 0.0 0 104865 2989
SD-Fhem1+/+ red blood cell distribution width- standard deviation control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait male 0 days 3 25.5 % 0.29 0.5 automated blood analysis 0.0 0 104909 2989
SD-Fhem1+/- blood monocyte count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. monocyte quantity male 0 days 3 3.3 % 0.4 0.7 automated blood analysis 0.0 0 104891 2989
SD-Fhem1+/+ blood eosinophil count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. eosinophil quantity male 0 days 3 1.0 % 0.12 0.2 automated blood analysis 0.0 0 104893 2989
SD-Fhem1+/- platelet-large cell ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait male 0 days 3 11.7 % 2.19 3.8 automated blood analysis 0.0 0 104923 2989
SD-Fhem1+/- blood aspartate aminotransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood aspartate transaminase amount male 0 days 3 124.3 U/l 5.6 9.7 automated blood analysis 0.0 0 104931 2989
SD-Fhem1+/- plasma indirect bilirubin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood bilirubin amount male 0 days 3 -0.6 umol/l 0.12 0.2 automated blood analysis 0.0 0 104951 2989
SD-Fhem1+/- blood protein measurement control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood total protein amount male 0 days 3 640.0 g/dl 7.51 13.0 automated blood analysis 0.0 0 104955 2989
SD-Fhem1+/- blood globulin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood globulin amount male 0 days 3 301.0 g/dl 6.35 11.0 automated blood analysis 0.0 0 104963 2989
SD-Fhem1+/- platelet count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet quantity female 0 days 3 964.3 x 1000 cells/ul 62.24 107.8 automated blood analysis 0.0 0 104864 2989
SD-Fhem1+/- blood lymphocyte count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. lymphocyte quantity male 0 days 3 1.7 x 1000 cells/ul 0.52 0.9 automated blood analysis 0.0 0 104899 2989
SD-Fhem1+/- red blood cell distribution width-coefficient of variation control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait male 0 days 3 19.6 % 0.81 1.4 automated blood analysis 0.0 0 104915 2989
SD-Fhem1+/+ blood lymphocyte count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. lymphocyte quantity male 0 days 3 58.5 % 3.41 5.9 automated blood analysis 0.0 0 104885 2989
SD-Fhem1+/+ blood monocyte count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. monocyte quantity female 0 days 3 4.5 % 0.52 0.9 automated blood analysis 0.0 0 104890 2989
SD-Fhem1+/- blood alanine aminotransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood alanine transaminase amount male 0 days 3 43.7 U/l 3.29 5.7 automated blood analysis 0.0 0 104927 2989
SD-Fhem1+/- blood aspartate aminotransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood aspartate transaminase amount female 0 days 3 100.5 U/l 5.66 9.8 automated blood analysis 0.0 0 104932 2989
SD-Fhem1+/+ blood alkaline phosphatase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood alkaline phosphatase amount female 0 days 3 36.0 U/l 17.9 31.0 automated blood analysis 0.0 0 104938 2989
SD-Fhem1+/- plasma indirect bilirubin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood bilirubin amount female 0 days 3 -0.2 umol/l 0.17 0.3 automated blood analysis 0.0 0 104952 2989
SD-Fhem1+/- blood globulin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood globulin amount female 0 days 3 305.0 g/dl 4.62 8.0 automated blood analysis 0.0 0 104964 2989
SD-Fhem1+/+ blood glucose level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood glucose amount female 0 days 3 115.2 mg/dl 14.55 25.2 automated blood analysis 0.0 0 104966 2989
SD-Fhem1+/- blood urea nitrogen level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood urea nitrogen amount female 0 days 3 920.0 mg/dl 57.74 100.0 automated blood analysis 0.0 0 104972 2989
SD-Fhem1+/+ blood creatine kinase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood creatine kinase amount male 0 days 3 36.7 IU/l 4.39 7.6 automated blood analysis 0.0 0 104981 2989
SD-Fhem1+/- blood creatine kinase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood creatine kinase amount male 0 days 3 41.0 IU/l 0.58 1.0 automated blood analysis 0.0 0 104983 2989
SD-Fhem1+/+ red blood cell count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte quantity male 0 days 3 8.6 x 10E6 cells/ul 0.12 0.2 automated blood cell counting method 0.0 0 104837 2989
SD-Fhem1+/+ red blood cell count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte quantity female 0 days 3 7.2 x 10E6 cells/ul 0.46 0.8 automated blood cell counting method 0.0 0 104838 2989
SD-Fhem1+/- mean platelet volume control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait male 0 days 3 8.1 fl 0.29 0.5 automated blood analysis 0.0 0 104867 2989
SD-Fhem1+/+ mean corpuscular hemoglobin control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount female 0 days 3 18.3 pg 0.46 0.8 automated blood analysis 0.0 0 104878 2989
SD-Fhem1+/+ plasma direct bilirubin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood bilirubin amount female 0 days 3 0.4 umol/l 0.12 0.2 automated blood analysis 0.0 0 104946 2989
SD-Fhem1+/+ blood glucose level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood glucose amount male 0 days 3 147.6 mg/dl 3.12 5.4 automated blood analysis 0.0 0 104965 2989
SD-Fhem1+/+ blood urea nitrogen level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood urea nitrogen amount male 0 days 3 780.0 mg/dl 28.87 50.0 automated blood analysis 0.0 0 104969 2989
SD-Fhem1+/+ blood creatine kinase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood creatine kinase amount female 0 days 3 35.0 IU/l 1.5 2.6 automated blood analysis 0.0 0 104982 2989
SD-Fhem1+/- blood hemoglobin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount male 0 days 3 1450.0 g/dl 40.41 70.0 automated blood analysis 0.0 0 104855 2989
SD-Fhem1+/- mean platelet volume control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait female 0 days 3 8.7 fl 0.23 0.4 automated blood analysis 0.0 0 104868 2989
SD-Fhem1+/+ mean corpuscular hemoglobin control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount male 0 days 3 16.9 pg 0.17 0.3 automated blood analysis 0.0 0 104877 2989
SD-Fhem1+/+ red blood cell distribution width- standard deviation control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait female 0 days 3 26.1 % 1.67 2.9 automated blood analysis 0.0 0 104910 2989
SD-Fhem1+/- blood lymphocyte count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. lymphocyte quantity female 0 days 3 57.8 % 4.56 7.9 automated blood analysis 0.0 0 104888 2989
SD-Fhem1+/- blood monocyte count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. monocyte quantity female 0 days 3 3.6 % 0.46 0.8 automated blood analysis 0.0 0 104892 2989
SD-Fhem1+/+ blood gamma-glutamyltransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood gamma-glutamyltransferase amount female 0 days 3 1.0 U/l 0.0 0.0 automated blood analysis 0.0 0 104934 2989
SD-Fhem1+/+ plasma indirect bilirubin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood bilirubin amount male 0 days 3 0.4 umol/l 0.06 0.1 automated blood analysis 0.0 0 104949 2989
SD-Fhem1+/+ plasma indirect bilirubin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood bilirubin amount female 0 days 3 0.1 umol/l 0.12 0.2 automated blood analysis 0.0 0 104950 2989
SD-Fhem1+/+ blood albumin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood albumin amount male 0 days 3 335.0 g/dl 9.81 17.0 automated blood analysis 0.0 0 104957 2989
SD-Fhem1+/+ blood hemoglobin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount female 0 days 3 1320.0 g/dl 75.63 131.0 automated blood analysis 0.0 0 104854 2989
SD-Fhem1+/- blood monocyte count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. leukocyte quantity female 0 days 3 0.1 x 1000 cells/ul 0.0 0.0 automated blood analysis 0.0 0 104904 2989
SD-Fhem1+/- blood eosinophil count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. eosinophil quantity male 0 days 3 0.04 x 1000 cells/ul 0.03 0.06 automated blood analysis 0.0 0 104907 2989
SD-Fhem1+/- red blood cell distribution width- standard deviation control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait male 0 days 3 28.0 % 0.98 1.7 automated blood analysis 0.0 0 104911 2989
SD-Fhem1+/- red blood cell distribution width-coefficient of variation control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait female 0 days 3 16.0 % 0.69 1.2 automated blood analysis 0.0 0 104916 2989
SD-Fhem1+/- blood eosinophil count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. eosinophil quantity male 0 days 3 1.0 % 0.52 0.9 automated blood analysis 0.0 0 104895 2989
SD-Fhem1+/+ blood lymphocyte count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. lymphocyte quantity male 0 days 3 3.8 x 1000 cells/ul 0.58 1.0 automated blood analysis 0.0 0 104897 2989
SD-Fhem1+/+ platelet distribution width control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait male 0 days 3 9.8 fl 0.4 0.7 automated blood analysis 0.0 0 104917 2989
SD-Fhem1+/- blood gamma-glutamyltransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood gamma-glutamyltransferase amount male 0 days 3 1.3 U/l 0.35 0.6 automated blood analysis 0.0 0 104935 2989
SD-Fhem1+/+ blood alkaline phosphatase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood alkaline phosphatase amount male 0 days 3 84.7 U/l 17.9 31.0 automated blood analysis 0.0 0 104937 2989
SD-Fhem1+/- plasma direct bilirubin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood bilirubin amount female 0 days 3 0.4 umol/l 0.12 0.2 automated blood analysis 0.0 0 104948 2989
SD-Fhem1+/- blood urea nitrogen level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood urea nitrogen amount male 0 days 3 810.0 mg/dl 28.87 50.0 automated blood analysis 0.0 0 104971 2989
SD-Fhem1+/- blood eosinophil count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. eosinophil quantity female 0 days 3 1.0 % 0.06 0.1 automated blood analysis 0.0 0 104896 2989
SD-Fhem1+/+ blood lymphocyte count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. lymphocyte quantity female 0 days 3 3.3 x 1000 cells/ul 0.75 1.3 automated blood analysis 0.0 0 104898 2989
SD-Fhem1+/- platelet-large cell ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait male 0 days 3 16.5 % 1.44 2.5 automated blood analysis 0.0 0 104921 2989
SD-Fhem1+/+ blood aspartate aminotransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood aspartate transaminase amount female 0 days 3 114.7 U/l 8.31 14.4 automated blood analysis 0.0 0 104930 2989
SD-Fhem1+/- blood alkaline phosphatase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood alkaline phosphatase amount male 0 days 3 38.0 U/l 5.43 9.4 automated blood analysis 0.0 0 104940 2989
SD-Fhem1+/+ blood hemoglobin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount male 0 days 3 1460.0 g/dl 28.87 50.0 automated blood analysis 0.0 0 104853 2989
SD-Fhem1+/+ hematocrit control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte quantity male 0 days 3 43.4 % 0.92 1.6 automated blood analysis 0.0 0 104857 2989
SD-Fhem1+/- hematocrit control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte quantity female 0 days 3 41.7 % 0.92 1.6 automated blood analysis 0.0 0 104860 2989
SD-Fhem1+/- mean corpuscular hemoglobin control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount male 0 days 3 16.2 pg 0.29 0.5 automated blood analysis 0.0 0 104879 2989
SD-Fhem1+/+ blood monocyte count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. leukocyte quantity female 0 days 3 0.3 x 1000 cells/ul 0.06 0.1 automated blood analysis 0.0 0 104902 2989
SD-Fhem1+/+ red blood cell distribution width-coefficient of variation control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait female 0 days 3 14.6 % 1.91 3.3 automated blood analysis 0.0 0 104914 2989
SD-Fhem1+/+ blood globulin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood globulin amount female 0 days 3 296.0 g/dl 34.64 60.0 automated blood analysis 0.0 0 104962 2989
SD-Fhem1+/+ blood urea nitrogen level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood urea nitrogen amount female 0 days 3 670.0 mg/dl 17.32 30.0 automated blood analysis 0.0 0 104970 2989
SD-Fhem1+/+ white blood cell count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. leukocyte quantity female 0 days 3 5.7 x 1000 cells/ul 0.64 1.1 automated blood cell counting method 0.0 0 104834 2989
SD-Fhem1+/- red blood cell count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte quantity male 0 days 3 8.9 x 10E6 cells/ul 0.17 0.3 automated blood cell counting method 0.0 0 104839 2989
SD-Fhem1+/- red blood cell count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte quantity female 0 days 3 8.1 x 10E6 cells/ul 0.17 0.3 automated blood cell counting method 0.0 0 104840 2989
SD-Fhem1+/+ blood protein measurement control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood total protein amount female 0 days 3 651.0 g/dl 57.16 99.0 automated blood analysis 0.0 0 104954 2989
SD-Fhem1+/+ blood albumin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood albumin amount female 0 days 3 355.0 g/dl 23.67 41.0 automated blood analysis 0.0 0 104958 2989
SD-Fhem1+/- blood albumin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood albumin amount female 0 days 3 373.0 g/dl 12.7 22.0 automated blood analysis 0.0 0 104960 2989
SD-Fhem1+/+ mean corpuscular volume control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait male 0 days 3 50.3 fl 0.52 0.9 automated blood analysis 0.0 0 104873 2989
SD-Fhem1+/+ red blood cell distribution width-coefficient of variation control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait male 0 days 3 17.3 % 0.4 0.7 automated blood analysis 0.0 0 104913 2989
SD-Fhem1+/+ blood aspartate aminotransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood aspartate transaminase amount male 0 days 3 130.3 U/l 5.83 10.1 automated blood analysis 0.0 0 104929 2989
SD-Fhem1+/+ blood gamma-glutamyltransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood gamma-glutamyltransferase amount male 0 days 3 1.3 U/l 0.35 0.6 automated blood analysis 0.0 0 104933 2989
SD-Fhem1+/- blood hemoglobin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount female 0 days 3 1450.0 g/dl 40.41 70.0 automated blood analysis 0.0 0 104856 2989
SD-Fhem1+/+ mean corpuscular volume control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait female 0 days 3 55.6 fl 1.96 3.4 automated blood analysis 0.0 0 104874 2989
SD-Fhem1+/+ blood monocyte count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. leukocyte quantity male 0 days 3 0.3 x 1000 cells/ul 0.12 0.2 automated blood analysis 0.0 0 104901 2989
SD-Fhem1+/- blood monocyte count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. leukocyte quantity male 0 days 3 0.4 x 1000 cells/ul 0.29 0.5 automated blood analysis 0.0 0 104903 2989
SD-Fhem1+/+ blood eosinophil count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. eosinophil quantity male 0 days 3 0.06 x 1000 cells/ul 0.01 0.01 automated blood analysis 0.0 0 104905 2989
SD-Fhem1+/+ blood eosinophil count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. eosinophil quantity female 0 days 3 0.1 x 1000 cells/ul 0.0 0.0 automated blood analysis 0.0 0 104906 2989
SD-Fhem1+/- red blood cell distribution width- standard deviation control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait female 0 days 3 25.6 % 0.69 1.2 automated blood analysis 0.0 0 104912 2989
SD-Fhem1+/+ mean corpuscular hemoglobin concentration control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount female 0 days 3 3303.0 g/dl 42.15 73.0 automated blood analysis 0.0 0 104882 2989
SD-Fhem1+/- mean corpuscular hemoglobin concentration control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount male 0 days 3 3443.0 g/dl 23.67 41.0 automated blood analysis 0.0 0 104883 2989
SD-Fhem1+/- mean corpuscular hemoglobin concentration control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount female 0 days 3 3433.0 g/dl 12.7 22.0 automated blood analysis 0.0 0 104884 2989
SD-Fhem1+/+ blood lymphocyte count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. lymphocyte quantity female 0 days 3 57.1 % 4.56 7.9 automated blood analysis 0.0 0 104886 2989
SD-Fhem1+/- blood lymphocyte count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. lymphocyte quantity male 0 days 3 50.7 % 4.04 7.0 automated blood analysis 0.0 0 104887 2989
SD-Fhem1+/+ blood eosinophil count to total leukocyte count ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. eosinophil quantity female 0 days 3 2.1 % 0.52 0.9 automated blood analysis 0.0 0 104894 2989
SD-Fhem1+/+ platelet distribution width control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait female 0 days 3 9.5 fl 0.29 0.5 automated blood analysis 0.0 0 104918 2989
SD-Fhem1+/- platelet distribution width control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait male 0 days 3 8.9 fl 0.58 1.0 automated blood analysis 0.0 0 104919 2989
SD-Fhem1+/- platelet-large cell ratio control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait female 0 days 3 16.1 % 1.62 2.8 automated blood analysis 0.0 0 104924 2989
SD-Fhem1+/- plasma direct bilirubin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood bilirubin amount male 0 days 3 0.3 umol/l 0.12 0.2 automated blood analysis 0.0 0 104947 2989
SD-Fhem1+/- blood creatine kinase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood creatine kinase amount female 0 days 3 34.5 IU/l 3.23 5.6 automated blood analysis 0.0 0 104984 2989
SD-Fhem1+/+ white blood cell count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. leukocyte quantity male 0 days 3 6.5 x 1000 cells/ul 0.81 1.4 automated blood cell counting method 0.0 0 104833 2989
SD-Fhem1+/- white blood cell count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. leukocyte quantity male 0 days 3 3.2 x 1000 cells/ul 0.52 0.9 automated blood cell counting method 0.0 0 104835 2989
SD-Fhem1+/- blood albumin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood albumin amount male 0 days 3 339.0 g/dl 5.2 9.0 automated blood analysis 0.0 0 104959 2989
SD-Fhem1+/+ blood globulin level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood globulin amount male 0 days 3 310.0 g/dl 1.15 2.0 automated blood analysis 0.0 0 104961 2989
SD-Fhem1+/- hematocrit control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte quantity male 0 days 3 42.1 % 0.92 1.6 automated blood analysis 0.0 0 104859 2989
SD-Fhem1+/- mean corpuscular volume control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. erythrocyte size trait male 0 days 3 47.2 fl 0.81 1.4 automated blood analysis 0.0 0 104875 2989
SD-Fhem1+/- mean corpuscular hemoglobin control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood hemoglobin amount female 0 days 3 17.7 pg 0.23 0.4 automated blood analysis 0.0 0 104880 2989
SD-Fhem1+/- blood lymphocyte count control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. lymphocyte quantity female 0 days 3 1.8 x 1000 cells/ul 0.29 0.5 automated blood analysis 0.0 0 104900 2989
SD-Fhem1+/- platelet distribution width control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. platelet size trait female 0 days 3 9.8 fl 0.4 0.7 automated blood analysis 0.0 0 104920 2989
SD-Fhem1+/+ blood alanine aminotransferase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood alanine transaminase amount female 0 days 3 36.3 U/l 1.85 3.2 automated blood analysis 0.0 0 104926 2989
SD-Fhem1+/- blood alkaline phosphatase activity level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood alkaline phosphatase amount male 0 days 3 69.3 U/l 2.6 4.5 automated blood analysis 0.0 0 104939 2989
SD-Fhem1+/- blood glucose level control condition Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. blood glucose amount male 0 days 3 129.6 mg/dl 4.16 7.2 automated blood analysis 0.0 0 104967 2989